New Food Invest
-
DATABASE (1659)
-
ARTICLES (741)
BASF Venture Capital is the investment arm of the BASF Group. Founded in 2001, the VC also has offices in Ludwigshafen, San Francisco, Boston, Austin, Shanghai, Sao Paulo, Mumbai and Tel Aviv.Global investments include stakes in young, fast-growing companies involved in agritech, chemistry, new materials, sustainability, digitalization and disruptive business models. The firm also holds shares in technology funds that target enterprises in Asia, North America and South America.
BASF Venture Capital is the investment arm of the BASF Group. Founded in 2001, the VC also has offices in Ludwigshafen, San Francisco, Boston, Austin, Shanghai, Sao Paulo, Mumbai and Tel Aviv.Global investments include stakes in young, fast-growing companies involved in agritech, chemistry, new materials, sustainability, digitalization and disruptive business models. The firm also holds shares in technology funds that target enterprises in Asia, North America and South America.
Bristol Myers Squibb or BMS is one of the world’s largest biopharmaceutical companies developing medicines in oncology, hematology, immunology and cardiovascular disease. It invests directly and via VC funds, including Life Sciences Partners (LSP) and BioGeneration Ventures, as LP. BMS is headquartered in New York and has 10 offices and facilities within the US and 13 in overseas locations, namely, Puerto Rico, Canada, France, Belgium, the UK, Ireland, Germany, Japan and China.
Bristol Myers Squibb or BMS is one of the world’s largest biopharmaceutical companies developing medicines in oncology, hematology, immunology and cardiovascular disease. It invests directly and via VC funds, including Life Sciences Partners (LSP) and BioGeneration Ventures, as LP. BMS is headquartered in New York and has 10 offices and facilities within the US and 13 in overseas locations, namely, Puerto Rico, Canada, France, Belgium, the UK, Ireland, Germany, Japan and China.
The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.
The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
PICC Capital Equity Investment Company
PICC Capital Equity Investment Company was founded in 2009 as a subsidiary of Chinese listed insurer PICC.In 2018, it set up a RMB 300m fund targeting health and elderly-care sectors. In 2020, the VC set up another fund to invest in cutting-edge technologies like biotech, integrated circuit, etc.
PICC Capital Equity Investment Company was founded in 2009 as a subsidiary of Chinese listed insurer PICC.In 2018, it set up a RMB 300m fund targeting health and elderly-care sectors. In 2020, the VC set up another fund to invest in cutting-edge technologies like biotech, integrated circuit, etc.
China's largest seed fund, ZhenFund was set up in 2011 by Xu Xiaoping (Bob Xu), Wang Qiang (Victor Wang) and Sequoia Capital China. The original ZhenFund (or ZhenFund 1.0) was founded in 2006 when Xu began investing as an angel investor, after the New Oriental Education & Technology Group he co-founded went public on NYSE. ZhenFund's notable investments include Jumei, Jiayuan, LightInTheBox, Miyabaobei, Meicai and 17zuoye, among the more than 300 startups it has betted on.
China's largest seed fund, ZhenFund was set up in 2011 by Xu Xiaoping (Bob Xu), Wang Qiang (Victor Wang) and Sequoia Capital China. The original ZhenFund (or ZhenFund 1.0) was founded in 2006 when Xu began investing as an angel investor, after the New Oriental Education & Technology Group he co-founded went public on NYSE. ZhenFund's notable investments include Jumei, Jiayuan, LightInTheBox, Miyabaobei, Meicai and 17zuoye, among the more than 300 startups it has betted on.
Captii Ventures focuses on building Southeast Asian based startups by providing access to entrepreneurial expertise and experience to support business growth and development. It is a multi stage investor, with a special interest in mobile tech startups, marketplace platforms that facilitate better matching of supply and demand and in new media that disrupts traditional communication channels. It likes startups that use technology to solve age old problems.
Captii Ventures focuses on building Southeast Asian based startups by providing access to entrepreneurial expertise and experience to support business growth and development. It is a multi stage investor, with a special interest in mobile tech startups, marketplace platforms that facilitate better matching of supply and demand and in new media that disrupts traditional communication channels. It likes startups that use technology to solve age old problems.
Coatue is a tech sector hedge fund that invests in public and private equity markets. It is run by Philippe Laffont, who founded the hedge fund after leaving Tiger Management in 1999. Coatue is based in New York City and has several other offices around the globe. Its Beijing office was set up in 2014 and has since invested in several notable Chinese startups, including Didi Chuxing, Mafengwo and Kuaikan Comic.
Coatue is a tech sector hedge fund that invests in public and private equity markets. It is run by Philippe Laffont, who founded the hedge fund after leaving Tiger Management in 1999. Coatue is based in New York City and has several other offices around the globe. Its Beijing office was set up in 2014 and has since invested in several notable Chinese startups, including Didi Chuxing, Mafengwo and Kuaikan Comic.
Yonghua is a specialized investment company under Yongjin Group. With more than 20 years investment experience, it has invested in more than 100 companies, more than 50 of which are listed. Yonghua focuses on the most competitive companies in industries such as finance, e-commerce, education, healthcare, corporation service, new material and artificial intelligence.
Yonghua is a specialized investment company under Yongjin Group. With more than 20 years investment experience, it has invested in more than 100 companies, more than 50 of which are listed. Yonghua focuses on the most competitive companies in industries such as finance, e-commerce, education, healthcare, corporation service, new material and artificial intelligence.
Established by the Shenzhen Government in 1999, Shenzhen Capital Group invests mainly in small- and medium-sized enterprises as well as high-tech startups in the fields of information technology, internet, biomedicine, new energy, high-end equipment manufacturing, etc. As of June 2018, it had invested RMB 37.6 billion in 889 projects and startups, 140 of which have been listed on 16 stock exchanges around the world.
Established by the Shenzhen Government in 1999, Shenzhen Capital Group invests mainly in small- and medium-sized enterprises as well as high-tech startups in the fields of information technology, internet, biomedicine, new energy, high-end equipment manufacturing, etc. As of June 2018, it had invested RMB 37.6 billion in 889 projects and startups, 140 of which have been listed on 16 stock exchanges around the world.
Patrick Walujo is the co-founder of Indonesian hedge fund Northstar Group. He had previously worked at Goldman, Sachs & Co. in London and New York before moving to Tokyo to join Pacific Capital Group. Ever since establishing Northstar Group in 2003, Patrick has overseen acquisitions and investments in notable Indonesian enterprises, including minimarket chain Alfamart, movie theater franchise Blitz Megaplex (now CGV Blitz after an investment from Korea's CJ CGV chain) and Equator Securities.
Patrick Walujo is the co-founder of Indonesian hedge fund Northstar Group. He had previously worked at Goldman, Sachs & Co. in London and New York before moving to Tokyo to join Pacific Capital Group. Ever since establishing Northstar Group in 2003, Patrick has overseen acquisitions and investments in notable Indonesian enterprises, including minimarket chain Alfamart, movie theater franchise Blitz Megaplex (now CGV Blitz after an investment from Korea's CJ CGV chain) and Equator Securities.
Based in New York, VectoIQ was formed in 2016 to fund startups in the smart mobility space. It is led by Steve Girsky, former vice-chairman of General Motors with more than 30 years in the automobile industry. Mary Chan is the managing partner, who also worked at GM as president of global connected consumer. The VC mainly invests in sectors relating to autonomous vehicles, connected car, smart mobility, MaaS, electrification and cybersecurity.
Based in New York, VectoIQ was formed in 2016 to fund startups in the smart mobility space. It is led by Steve Girsky, former vice-chairman of General Motors with more than 30 years in the automobile industry. Mary Chan is the managing partner, who also worked at GM as president of global connected consumer. The VC mainly invests in sectors relating to autonomous vehicles, connected car, smart mobility, MaaS, electrification and cybersecurity.
CEO and Co-founder of 17zuoye
Former senior teacher and executive at New Oriental Education & Technology Group Inc., the largest provider of private educational services in China. He singlehandedly founded its office in Changchun. Described by Xiaomi CEO and founder Lei Jun as “a founder without flaws”.
Former senior teacher and executive at New Oriental Education & Technology Group Inc., the largest provider of private educational services in China. He singlehandedly founded its office in Changchun. Described by Xiaomi CEO and founder Lei Jun as “a founder without flaws”.
Co-founder and co-CEO of Shotl
Osvald Martret is the chairman of Drivania Chauffeurs co-founded by the Martret brothers in 2001, now transformed into Drivania International with operations in Europe and the US. In 2001, the Martrets also established mobility venture builder Camina Lab in New York.Martret graduated in Nautical Science at Barcelona Polytechnic University and has a master's in International Transport from Pontificia de Comillas University in Madrid. He worked as a transport manager at MAXAM that transports dangerous substances and was operations manager at shipping agency Transcoma. In 2016, he became co-CEO of Shotl, another Martret transportation startup in Barcelona.
Osvald Martret is the chairman of Drivania Chauffeurs co-founded by the Martret brothers in 2001, now transformed into Drivania International with operations in Europe and the US. In 2001, the Martrets also established mobility venture builder Camina Lab in New York.Martret graduated in Nautical Science at Barcelona Polytechnic University and has a master's in International Transport from Pontificia de Comillas University in Madrid. He worked as a transport manager at MAXAM that transports dangerous substances and was operations manager at shipping agency Transcoma. In 2016, he became co-CEO of Shotl, another Martret transportation startup in Barcelona.
Traveloka is an Indonesian online travel agency that reached unicorn status in 2017 after receiving funding from Expedia. It has since added new services, including hotel and car rental bookings to its offerings.
Traveloka is an Indonesian online travel agency that reached unicorn status in 2017 after receiving funding from Expedia. It has since added new services, including hotel and car rental bookings to its offerings.
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
New Food Invest: Plant-based cheese, the next investment boom?
With alt-protein startups experiencing a global funding boom, industry experts and investors share their views about emerging trends in diverse food sectors
New Food Invest: Challenges of growing an alt-protein startup
Founders of three alt-protein startups in the US share what motivated them to start, their personal experiences growing the businesses, getting funding and finding strategic partners
New Food Invest: Opportunities in the European alt-protein space
With a record €2.4bn investment in 2019, Europe’s foodtech sector appears poised for continued growth, but startups, corporations, governments and even universities can do more, experts say
New Food Invest: Building a plant-based business in the US
With plant-based startups experiencing exponential growth but facing increasingly intense competition, experts consider the opportunities and barriers in the sector
OLIO: Zero food waste app expands with new product categories, going global
Recent $43m Series B funding will let sustainability app more than triple hiring, add homemade products and household goods to product listings
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
Future Food Asia: Temasek, Continental Grain on investing in agrifood in Singapore and China
The two heavyweight investors discuss opportunities, needs and how agrifood startups can scale in Asian markets
Bayer Growth Ventures' Paimun Amini: Invest in tech for smarter, more sustainable farming
Corporate venture capital showed up in abundance at Smart Agrifood Malaga, where CompassList spoke with Paimun Amini, Director of Venture Investments for Bayer Growth Ventures (BGV)
Future Food Asia 2021: Impact assessments – getting the metrics right
Common impact measures are useful but each situation requires specific, sometimes subjective considerations. The priority is to gauge if the impact has led to positive changes
Future Food Asia 2021: Regenerative agriculture in Asia
The unique challenges facing regenerative agriculture in Asia require solutions different from those in the West, presenting opportunities for microfinancing and impact investment
Shilling Capital Partners: Growing Portuguese tech businesses from seed
An early mover, the influential angel investing firm is accelerating local techs into Brazil and globally
AquaCultured Foods: World's first whole-cut vegan seafood made through microbial fermentation
Armed with its fermentation technology and proprietary strain of fungi, AquaCultured is closing an oversubscribed funding round, raising more than $1.5m to launch its non-GMO seafood alternatives, with plans to expand to more food verticals and overseas
SWITCH Singapore: Race in agrifood tech as a solution to feeding 10bn people
While the potential gains are huge, giving tech solutions to farmers, especially smallholders in developing countries, remains a work in progress
Les Nouveaux Affineurs: Disrupting centuries-old French cheese culture
Backed by Michelin-star chefs and investors, Les Noveaux Affineurs is gearing up to be a global player in the billion-dollar vegan cheese market
Sorry, we couldn’t find any matches for “New Food Invest”.
